ArticleFrontiers in oncology2022

Concomitant Kinase-Dead BRAF and Oncogenic KRAS Lead to an Aggressive Biologic Behavior and Tumor Lysis Syndrome: A Case Report.

Roy Holland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.